Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems
Rashid Kazerooni, 1 Ileana M Howard, 2, 3 Adrienne M Keener, 4, 5 Mark Bounthavong 6, 7 1Merz Pharmaceuticals, LLC, Raleigh, NC, 27615, USA; 2Rehabilitation Care Services, VA Puget Sound, Seattle, WA, USA; 3Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA; 4Depar...
Main Authors: | Kazerooni R, Howard IM, Keener AM, Bounthavong M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-06-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/real-world-six-year-national-cost-minimization-analysis-of-incobotulin-peer-reviewed-fulltext-article-CEOR |
Similar Items
-
OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays
by: David Rupp, et al.
Published: (2020-06-01) -
Prospective evaluation of incobotulinumtoxinA in the management of the masseter using two different injection techniques
by: Nikolis A, et al.
Published: (2018-07-01) -
Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01) -
Long-term Dose Stability of OnabotulinumtoxinA Injection for Adductor Spasmodic Dysphonia: A 19-Year Single Institution Experience
by: Paul Paddle, et al.
Published: (2017-11-01) -
Botulinum Toxin : Formulation, Concentration and Treatment
by: Rystedt, Alma
Published: (2012)